The Series B-1 investment comes from health care venture capital firm Frist Cressey Ventures of Nashville, Tennessee. The Frist Cressey investment follows a $20 million Series B fundraise that Axuall announced in May and brings the company's total raise to date to more than $41 million.
Axuall is an Ohio-based SaaS platform that provides solutions such as clinical workforce intelligence, analytics, and network planning for the healthcare industry.